Company intelligence / Profile preview

Adva Diagnostics

Winnipeg, Manitoba, Canada

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Adva Diagnostics has developed a rapid, high-throughput spot test system based on spectral technology to detect infectious diseases, initially for COVID-19, with the ability to simultaneously analyze up to 384 samples in five minutes, distinguishing SARS-CoV-2 from other pathogens and expanding as its spectral database grows; supported by 14 patents in 24 countries and external validation from Canadian governmental agencies

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Molecular Diagnostics

Partnerships

Research ManitobaMitacs

Beyond the preview

Go deeper on Adva Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adva Diagnostics.

Explore the full profile